Histological variants of cutaneous Kaposi sarcoma by Grayson, Wayne & Pantanowitz, Liron
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Diagnostic Pathology
Open Access Review
Histological variants of cutaneous Kaposi sarcoma
Wayne Grayson1 and Liron Pantanowitz*2
Address: 1Histopathology Department, Ampath National Laboratory Support Services, Johannesburg, South Africa and 2Department of Pathology, 
Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts, USA
Email: Wayne Grayson - wayne.grayson@live.com; Liron Pantanowitz* - Liron.pantanowitz@bhs.org
* Corresponding author    
Abstract
This review provides a comprehensive overview of the broad clinicopathologic spectrum of
cutaneous Kaposi sarcoma (KS) lesions. Variants discussed include: usual KS lesions associated with
disease progression (i.e. patch, plaque and nodular stage); morphologic subtypes alluded to in the
older literature such as anaplastic and telangiectatic KS, as well as several lymphedematous variants;
and numerous recently described variants including hyperkeratotic, keloidal, micronodular,
pyogenic granuloma-like, ecchymotic, and intravascular KS. Involuting lesions as a result of
treatment related regression are also presented.
Introduction
Kaposi sarcoma (KS) is a vascular lesion of low-grade
malignant potential that presents most frequently with
skin lesions. Most histopathologists are au fait with the
histologic picture of usual (typical) cutaneous KS as it
progresses from patch, to plaque and finally nodular
stages [1-4]. This morphologic spectrum of "usual" KS is
common to classic, African endemic, transplant-associ-
ated, and acquired immune deficiency syndrome (AIDS)-
associated KS [4]. In recent decades, however, there has
been an increasing awareness of a wider histologic spec-
trum [5,6]. This has resulted in a growing number of
reported clinical and/or histologic variants of KS. Failure
to identify a given lesion as KS could lead to delayed diag-
nosis or inappropriate management. It has also been sug-
gested that certain variants, such as anaplastic KS and
possibly lymphangioma-like KS, might have prognostic
relevance [7-9].
Taking these factors into account, we have elected to
divide KS skin lesions into four broad groups: (1) KS
lesions which encompass usual variants related to disease
progression, (2) KS variants alluded to in the older litera-
ture, (3) more recently described KS variants, and (4) KS
lesions as a consequence of therapy. Although the appar-
ent histogenesis of some of these morphologic variants is
known, the pathogenesis of others is uncertain or subject
to speculation. Hyperkeratotic KS, by way of example, fre-
quently occurs as a result of KS-associated chronic lymph-
edema of the lower extremities [10]. Intravascular KS, on
the other hand, could either originate primarily as an
intravascular proliferation, or alternatively develop as a
consequence of intravascular extension of a lesion breach-
ing the vessel wall [11]. KS lesions arising in extracutane-
ous locations often differ histologically from their
counterparts in the skin, including the recent description
of "in situ" KS involving mediastinal lymphatic vessels
[12].
Usual variants related to progression
Patch stage
Patch stage KS, which represents the earliest phase in the
evolution of cutaneous KS, is perhaps the histologic vari-
ant with the greatest propensity to cause diagnostic diffi-
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culties for the unwary. The initial low-power impressions
are those of a "busy" dermis, or perhaps some form of
mild inflammatory dermatosis [1,13]. On closer examina-
tion, however, there are signs of a subtle vasoformative
process composed of newly formed slit-like or somewhat
jagged vascular spaces, which tend to be more conspicu-
ous in the immediate vicinity of native dermal vessels and
cutaneous appendages [1-4]. The protrusion of these
native microscopic vascular structures into the lumens of
more ectatic neoplastic channels results in the characteris-
tic promontory sign (Figure 1). The intervening dermis
frequently reveals dissection of its collagen bundles by
slit-like vascular spaces lined by a monolayer of relatively
banal, flattened endothelial cells, with a variable degree of
erythrocyte extravasation. The newly formed channels
often contain red blood cells. There is also a noticeable
mild background inflammatory cell infiltrate comprising
lymphocytes and plasma cells, often accompanied by a
contingent of hemosiderin-laden macropahges. The
aforementioned mononuclear cells tend to be concen-
trated around the native vessels and skin adnexal struc-
tures [1-4].
Plaque stage
In plaque stage lesions of KS, the histologic picture is char-
acterized by a more diffuse dermal vascular infiltrate,
accompanied by greater cellularity and occasional exten-
sion of this process into the underlying subcutaneous adi-
pose tissue. The lesional cells tend to be more spindled
and arranged in short, sometimes haphazard fascicles [1-
4]. Fascicles cut in cross section demonstrate a sieve-like
appearance. Mitotic figures are sparse and there is no sig-
nificant nuclear or cytological pleomorphism. Intra- and
extracellular hyaline globules, probably representing
effete erythrocytes, are often seen. Careful scrutiny will fre-
quently reveal "autolumination", whereby an erythrocyte
is contained within a clear paranuclear vacuole in the
cytoplasm of a spindled endothelial cell observed in cross
section (Figure 2). Numerous dissecting vascular channels
containing erythrocytes occupy the intervening dermis,
and once again there is evidence of a background plasma
cell-rich contingent of chronic inflammatory cells with
admixed siderophages and free-lying hemosiderin pig-
ment. The promontory sign, as described above, may also
be encountered [1-4]. The histologic differential diagnosis
includes tufted angioma, targetoid hemosiderotic heman-
gioma, microvenular hemangioma and acroangioderma-
titis ("pseudo-Kaposi's sarcoma") [1,2,4].
Nodular stage
The nodular form of KS usually poses no diagnostic diffi-
culties. Occasionally, however, a small ulcerated nodular
KS lesion may be mistaken for a pyogenic granuloma [1].
Nodular KS exhibits dermal expansion by a relatively cir-
cumscribed, variable cellular proliferation of neoplastic
spindled cells arranged in fascicles (Figure 4) [1-4]. Eryth-
rocytes are contained within slit-like channels between
the individual spindled cells. Although careful inspection
may reveal occasional mitoses, the lesional cells are rela-
Patch stage Kaposi sarcoma showing newly formed vessels  protruding into a larger vascular space characteristic of the  promontory sign (H&E stain) Figure 1
Patch stage Kaposi sarcoma showing newly formed 
vessels protruding into a larger vascular space char-
acteristic of the promontory sign (H&E stain).
Plaque stage Kaposi sarcoma Figure 2
Plaque stage Kaposi sarcoma. Large numbers of intracel-
lular and extracellular eosinophilic hyaline globules are visible 
in this field (H&E stain). The arrows indicate so-called "auto-
lumination", with paranuclear vacuoles containing erythro-
cytes.Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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tively monomorphic. Hyaline globules are seen more
readily, as is the phenomenon of autolumination. In
larger punch biopsy or excision biopsy specimens, the
dermis away from the tumor nodule frequently exhibits
changes associated with plaque stage KS, thus supporting
the notion that patch, plaque and nodular stage lesions
form part of a morphologic continuum. The periphery of
some nodular KS lesions may show more dilated vascular
spaces, imparting a pattern that is strikingly reminiscent
of a cavernous hemangioma (Figure 4) [2]. These larger,
congested channels are an integral part of the lesion, as
confirmed by positive immunohistochemical staining of
the lining endothelial nuclei for HHV-8 latent nuclear
antigen 1 (LNA-1).
Large cutaneous nodules may frequently undergo ulcera-
tion. Superficial shave biopsies of such lesions may be
diagnostically challenging to the histopathologist, as
most of the specimen may contain only an inflammatory
exudate with underlying granulation tissue; this may be
misinterpreted as a pyogenic granuloma [1]. Distinguish-
ing between spindle cells from granulation tissue and
lesional KS cells from the uppermost portion of an under-
lying KS nodule can be difficult, if not impossible without
the aid of immunohistochemistry. The commercial anti-
body to HHV-8 LNA-1 and the lymphatic endothelial cell
marker D2-40 may prove very useful in this context. Stain-
ing with these markers is preferable to less specific vascu-
lar markers such as CD31 or CD34, as these do not
facilitate recognition of the lesional and non-lesional
endothelial cell populations. Rare instances of acquired
immune deficiency syndrome (AIDS)-associated KS har-
boring a concomitant opportunistic pathogen (e.g. cryp-
tococcosis) may also go undiagnosed in superficial biopsy
material [14,15]. Superficial shave biopsies, therefore,
should be discouraged.
Lesions that may potentially be confused histologically
with nodular KS include bacillary angiomatosis, other
vascular tumors (e.g. spindle cell hemangioma and
Kaposiform hemangioendothelioma), fibrohistiocytic
tumors (e.g. cellular, angiomatoid and atypical variants of
fibrous histiocytoma, and dermatofibrosarcoma protu-
berans), resolving dermal fasciitis, spindle cell melanoma,
and several other spindle cell mesenchymal neoplasms
(e.g. cutaneous leiomyosarcoma) [1,2,4].
Variants reported in the older literature
Anaplastic Kaposi sarcoma
Anaplastic KS, sometimes referred to as pleomorphic KS,
is poorly documented in the literature, possibly because
of its rarity. Malignant transformation of KS, characterized
by an increase in the number of mitoses and marked cel-
lular pleomorphism, was first described in 1959 by Cox
and Helwig [16]. A "monomorphic" variant was identi-
fied by Templeton in several cases of African KS [17]. In a
review of KS cases from Uganda (in 1971), investigators
distinguished KS with a "monocellular pattern" (resem-
bling anaplastic KS) from a so-called "anaplastic variant
pattern" (resembling angiosarcoma) [18]. Anaplastic his-
tology has been described in the context of classic, African,
and AIDS-associated KS [7,8,19-24]. We are unaware of a
Nodular Kaposi sarcoma Figure 3
Nodular Kaposi sarcoma.A. The dermis is expanded by a 
solid tumor nodule (H&E stain). B. Fascicles of relatively 
monomorphic spindled cells, with slit-like vascular channels 
containing erythrocytes (H&E stain). C. The nuclei of the 
tumor cells demonstrate immunoreactivity for HHV-8 (LNA-
1 immunohistochemical stain).
Nodular Kaposi sarcoma showing a peripheral component at  higher magnification reminiscent of a cavernous hemangioma  (H&E stain) Figure 4
Nodular Kaposi sarcoma showing a peripheral com-
ponent at higher magnification reminiscent of a cav-
ernous hemangioma (H&E stain).Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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report of this rare variant following iatrogenic immuno-
suppression.
Anaplastic KS is clinically notable for its high local aggres-
siveness, propensity for deep invasion, and increased met-
astatic capacity. Progressive histologic dedifferentiation in
otherwise typical cases of KS has been noted (Figure pend-
ing permission) [22,25]. AIDS-associated tumors with
anaplastic histology appear to have a propensity to occur
in acral locations. In anaplastic KS, there is inherent
potential for misdiagnosis as the vasoformative nature of
the solid and frequently fascicular spindle cell prolifera-
tion is not readily apparent. This variant displays a signif-
icantly greater degree of nuclear and cellular
pleomorphism than conventional nodular KS (Figure 5).
In addition, there is an increased mitotic index (e.g. 5–20
mitoses per 10 high-power fields), and atypical mitoses
may be encountered. Necrosis is occasionally observed.
It is easy to appreciate why a host of other malignant spin-
dle cell neoplasms might be entertained in the histologic
differential diagnosis, including certain sarcomas (e.g. lei-
omyosarcoma, spindle cell rhabdomyosarcoma, malig-
nant peripheral nerve sheath tumor, fibrosarcoma),
amelanotic spindle cell melanoma, and spindle cell carci-
noma [14,15,20]. Angiosarcoma might also be consid-
ered, particularly if erythrocytes are identified between the
markedly atypical spindled cells. A comprehensive panel
of immunohistochemical stains is often required to rule
out the aforementioned entities and confirm the presence
of KS [15]. It is plausible that a proportion of anaplastic
KS cases reported in the earlier literature, prior to the
advent of immunohistochemistry, might not have been
true cases of KS after all.
Lymphedematous variants
There are several variants of lymphedematous KS, all of
which can present clinically with a deceptive bulla-like
appearance (Figures pending permission). The inter-
changeable terminology that has been used in the litera-
ture for these variants is confusing. An attempt to classify
this issue has been made [26], and includes variants asso-
ciated with ectatic lymphatics such as lymphangioma-like
and lymphangiectactic KS, and/or due to the accumula-
tion of superficial dermal edema such as the subepider-
mal and intraepidermal (lymphatic) bullous KS variants.
Most of these variants usually contain an admixture of
more stereotypical KS lesions. In those cases where these
lymphedematous variants form the predominant or sole
histological pattern, the diagnosis of KS may be problem-
atic.
Lymphangioma-like KS
Lymphangioma-like KS (LLKS), also referred to as "lym-
pangiomatous" KS, is an uncommon variant that may be
encountered in all four major clinicopathologic groups of
KS patients [27-33]. Furthermore, lymphangioma-like
morphology can occur in patch, plaque or nodular stage
lesions [26]. This variant is said to account for less than
5% of KS cases [29]. Although Ronchese and Kern in 1957
are often credited with first describing the condition, the
first reported case actually appears to date back to 1923,
noted in a 66-year-old woman with clinical bullous KS
lesions, the histology of which was described as being
analogous to lymphangioma circumscriptum [27,34].
LLKS is most likely related to lymphedematous KS, bul-
lous KS and hyperkeratotic (or verrucous) KS, as many of
the reported patients with these clinical variants of KS
have shown histopathologic features of LLKS on skin
biopsy [10,26,27,34-39]. In some case reports patients
with LLKS manifested with widespread and pronounced
lymphedema [40] as well as effusions [41].
LLKS appears to exist (or co-exist) in two forms micro-
scopically. The first comprises a patch or plaque stage
lesion in which irregular, ectatic, interanastomosing vas-
cular channels dissect dermal collagen bundles, resulting
in a striking histological resemblance to a lymphatic
tumor, such as a benign lymphangioendothelioma/
acquired progressive lymphangioma (Figure 6)
[31,32,42]. In these cases the promontory sign tends to be
particularly conspicuous (Figure 7). Erythrocytes are usu-
ally absent from these channels. Slender papillae may
project into vessels. In the second form, much larger, well
Anaplastic Kaposi sarcoma Figure 5
Anaplastic Kaposi sarcoma. A. Solid, haphazard prolifer-
ation of atypical spindled cells, with little evidence to suggest 
a vasoformative tumor (H&E stain). B. CD31 immunostain 
confirming the presence of a solid proliferation of atypical 
endothelial cells. C. LNA-1 immunostain for HHV-8 demon-
strating positive immunoreactivity in the nuclei of several ple-
omorphic lesional cells.Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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formed endothelial lined spaces occupy the papillary der-
mis and the upper reticular dermis (Figure 8). These chan-
nels may closely abut on the overlying epidermis, in a
pattern somewhat analogous to lymphangioma circum-
scriptum. It is the latter pattern which may give rise to the
clinical appearance of "bullous" cutaneous lesions. Fea-
tures of usual plaque stage KS are often encountered sub-
jacent to these large channels; this useful diagnostic clue
may be absent from biopsies that are too superficial, espe-
cially shave biopsies. The endothelial cells lining the
ectatic, lymphangioma-like channels in both forms are
immunoreactive for HHV-8 LNA-1, as well as the lym-
phatic endothelial marker D2-40 (Figure 8).
Lymphangiectatic Kaposi sarcoma
In lymphangiectactic KS there are large intratumoral and
peritumoral dilated thin-walled lymphatic vessels (Figure
9). These ectatic lymphatics are much larger than those
seen in LLKS, and less irregular and anastomosing [26].
They appear to be far less "compressible". Marked lym-
phangiectasia present in the superficial dermis may result
in a bullous appearing lesion (pseudoblister).
Bullous Kaposi sarcoma
The first published descriptions of bullous cutaneous
lesions in patients with KS appeared in the early part of
the twentieth century. These bullous lesions were ascribed
to lymphangiectases [34]. Bullous lesions are observed
most frequently in the context of lymphedematous KS,
but this is not always the case [26,34]. In most instances,
the term "bullous" is clinical rather than pathologic, since
Lymphangioma-like Kaposi sarcoma Figure 6
Lymphangioma-like Kaposi sarcoma. In this florid 
example, the dermis is replaced by a haphazard proliferation 
of gaping, interanastomosing channels splaying apart the der-
mal collagen (H&E stain).
Lymphangioma-like Kaposi sarcoma seen at higher magnifica- tion in which the promontory sign is well demonstrated  (H&E stain) Figure 7
Lymphangioma-like Kaposi sarcoma seen at higher 
magnification in which the promontory sign is well 
demonstrated (H&E stain).
Lymphangioma-like Kaposi sarcoma Figure 8
Lymphangioma-like Kaposi sarcoma. A. Low-power 
photomicrograph depicting the upper dermal expansion by a 
proliferation that is distinctly reminiscent of a lymphatic neo-
plasm or malformation. Note the reactive epidermal hyper-
plasia and hyperkeratosis (H&E stain). B. Closer view of the 
"lymphangiomatous" proliferation, with each gaping channel 
lined by a monolayer of plump Kaposi sarcoma cells, and 
frothy, pale eosinophilic intraluminal fluid resembling lymph 
(H&E stain). C. Positive staining of lining cells with the lym-
phatic endothelial marker D2-40. D. Nuclei of the same cel-
lular population show immunoreactivity for LNA-1.Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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pseudoblisters also occur as a consequence of lym-
phangiectasia and/or LLKS involving the superficial der-
mis in these patients (Figure 10) [26]. On other occasions,
however, true subepidermal or intraepidermal bullae may
arise in concert with KS. In the former, tense bullae are
observed clinically due to peritumoral edema in the
superficial dermis, while the latter may evolve either as a
result of progression of a subepidermal bulla or due to
resorption of lymphedema and re-epithelialization of a
subepidermal blister [26].
Telangiectatic KS
There is a single case report of telangiectatic KS, which
occurred in a man with thymoma and myasthenia gravis
receiving long-term immunosuppressive therapy [43].
The term "telangiectatic" referred to the significant tel-
angiectasia associated with the multiple cutaneous nod-
ules, and not the histopathologic features thereof. The
histopathology in this case report showed usual features
of nodular KS, with no conspicuous background vascular
ectasia [43]. The authors have encountered rare histologi-
cal examples of telangiectatic KS in which nodular KS
lesions contained large, intensely congested, ectatic vascu-
lar spaces (Figure 11). Since these large spaces are lined by
endothelial cells (Figure 12) whose nuclei are immunore-
active for LNA-1, it must be assumed that they are an inte-
gral part of the KS and not merely native dermal vessels
Lymphangiectactic Kaposi sarcoma Figure 9
Lymphangiectactic Kaposi sarcoma. Large ecstatic lym-
phatics can be seen within and around this KS tumor nodule 
(H&E stain).
Bullous Kaposi sarcoma Figure 10
Bullous Kaposi sarcoma. In this patient with African 
endemic KS there is an intraepidermal bullous overlying sub-
epidermal lymphedema associated with an underlying KS 
tumor nodule (not shown in this field) (H&E stain).
Telangiectatic Kaposi sarcoma is characterized by intensely  congested, ectatic vascular spaces lined by lesional cells (H&E  stain) Figure 11
Telangiectatic Kaposi sarcoma is characterized by 
intensely congested, ectatic vascular spaces lined by 
lesional cells (H&E stain).Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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that have undergone telangiectasia as a consequence of
compression by the dermal tumor.
Contemporary variants
Hyperkeratotic (Verrucous) Kaposi sarcoma
Hyperkeratotic KS is a rarely described clinicopathalogic
variant of KS, which appears to be closely linked to severe
KS-associated lymphedema in patients with AIDS
[10,35,44]. There is verrucous epidermal acanthosis and
hyperkeratosis overlying an often fibrotic epidermis (Fig-
ure 13). In view of the latter feature, diagnostic KS lesional
tissue may be located at a relatively deeper level in the der-
mis, further emphasizing the potential inadequacy of
superficial shave biopsies. On occasion, verrucoid epider-
mal changes may occur with LLKS histology (Figure 14).
Infrequently, such changes may involve the entire lower
extremity manifesting as elephantiasis nostras verrucosa
[45]. Chronic lymphedema may itself give rise to verruci-
form epidermal hyperplasia and hyperkeratosis, with
increased fibroblastic activity, blood vessels and thick-
walled lymphatic vessels throughout the dermis [39].
Lympedematous AIDS-associated KS may also be associ-
ated with exophytic fibroma-like nodules, characterized
by dermal fibrosis, a loose arrangement of fibroblasts and
collagen bundles, and dilated blood vessels and lym-
phatic channels [10,39,44].
Keloidal Kaposi sarcoma
The description of this exceedingly uncommon KS variant
is limited to a 1994 report of three cases [46]. Lesions are
firm and rubbery, and may be linear [6]. Histologically,
there is notable dermal expansion by dense, hyalinized
collagen with a distinct resemblance to a keloid (Figure
15). In such lesions the spindled KS proliferation may be
obscured by these keloidal alterations. The histologic dif-
ferential diagnosis includes a dermal scar at the site of a
previous skin biopsy of a KS lesion. It is postulated that
cytokines play a key role in the evolution of the keloidal
stromal changes in this unusual variant [46].
Micronodular KS
Micronodular KS (Figure 16) is a recently described vari-
ant of nodular KS, which is characterized histologically by
a small, unencapsulated, circumscribed spindle cell prolif-
eration in the reticular dermis [47]. Although the paper by
Kempf et al described micronodular cutaneous lesions in
a patient with classic KS [47], similar lesions are occasion-
ally encountered in the context of AIDS-associated KS,
and are often removed in their entirety by a punch biopsy.
A CD31 immunostain highlights the many dilated vascular  spaces seen in telangiectatic Kaposi sarcoma Figure 12
A CD31 immunostain highlights the many dilated 
vascular spaces seen in telangiectatic Kaposi sar-
coma.
Hyperkeratotic (verrucous) Kaposi sarcoma Figure 13
Hyperkeratotic (verrucous) Kaposi sarcoma. A plaque 
stage lesion from the lower leg is surfaced by an epidermis 
showing verruciform acanthosis and hyperkeratosis, with 
fibrosis of the upper dermis (H&E stain).
Kaposi sarcoma with hyperkeratotic and lymphangioma-like  histologic features (H&E stain) Figure 14
Kaposi sarcoma with hyperkeratotic and lymphangi-
oma-like histologic features (H&E stain). Note the 
dilated channels in the dermis and the marked acanthosis, 
and hyperkeratosis of the overlying epidermis.Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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Pyogenic granuloma-like Kaposi sarcoma
Small, superficially located nodular or micronodular KS
lesions may be protuberant and thereby elicit the develop-
ment of a peripheral epidermal collarette (Figure 17).
Such lesions have been referred to as pyogenic granuloma
(PG)-like KS [48]. Traumatized lesions may undergo
ulceration and become inflamed, and potentially misdi-
agnosed as a true PG (lobular capillary hemangioma). To
further complicate matters true PGs may themselves har-
bor kaposiform areas. PG-like KS must also be distin-
guished from bacillary angiomatosis, as some examples of
the latter can adopt striking PG-like low-power architec-
ture [14,15].
Ecchymotic Kaposi sarcoma
In the variant referred to as ecchymotic KS, the intrader-
mal KS proliferation is accompanied by extensive red
blood cell extravasation (Figure 18) [49]. The marked pur-
pura often obscures the underlying histologic features of
KS. The differential diagnosis includes intralesional hem-
orrhage brought about the biopsy procedure itself. Clini-
cally, this variant of AIDS-associated KS manifests with
ecchymotic or pityriasis-like patches [49]. Ecchymotic
plaque lesions may clinically also resemble a bruise or
port-wine stain. A rare case of clinical "hemorrhagic" KS
has been reported [50]. However, it is unclear if the
appearance in this case was attributed to extensive eryth-
rocyte extravassation.
Intravascular Kaposi sarcoma
The only description of intravascular KS is limited to a
report of six cases, including four patients with classic KS
and two with AIDS-associated KS [11]. Histologic exami-
nation in this small series showed an exclusively intravas-
cular solid spindle cell KS proliferation.
Immunohistochemical stains for desmin and smooth
muscle actin (SMA) confirmed that this proliferation was
indeed intravenous. The histologic differential diagnosis
includes intravascular papillary endothelial hyperplasia,
intravenous PG, intravascular fasciitis, papillary intralym-
phatic angioendothelioma (Dabska tumor) and intravas-
cular myopericytoma [51].
Keloidal Kaposi sarcoma Figure 15
Keloidal Kaposi sarcoma.A. Spindled cells from the edge 
of the Kaposi sarcoma plaque lesion (upper left) are flanked 
by an expanse of keloid-like collagen (lower right) (H&E 
stain). B. Masson's trichrome stain highlighting the keloidal 
collagen bundles. Note the many extravasated erythrocytes 
in the background.
Micronodular Kaposi sarcoma Figure 16
Micronodular Kaposi sarcoma. A small, solid circum-
scribed spindle cell proliferation is present in the mid- to 
lower dermis (H&E stain).Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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Variants related to therapy
Therapy may result in KS regression, and less likely exac-
erbation (so-called KS flare) [52]. The histopathology of
regression in KS has been previously described and is dis-
cussed below. KS exacerbation (flare or recrudescence)
can occur following therapy with corticosteroids, after
treatment with rituximab, or as part of the immune recon-
stitution inflammatory syndrome (IRIS) seen with antiret-
roviral therapy in HIV-infected persons [52]. The
histomorphology of KS flare lesions has yet to be
described.
Regressing Kaposi sarcoma
The introduction of highly active antiretroviral therapy
(HAART) for patients with human immunodeficiency
virus infection (HIV) may lead to complete regression of
established AIDS-associated KS lesions [53,54]. Clinical
features of regression include flattening of lesions, reduc-
tion in lesion size, and change from a purple-red appear-
ance to an orange-brown macule. Following antiretroviral
therapy, investigators have observed improved circum-
scription of nodular lesions, which appear less cellular
and are enveloped by a densely sclerotic stroma [55]. In
some cases the only significant abnormalities are an
increase in dermal capillary density around native dermal
vessels and appendages (Figure 19), and an accompany-
ing perivascular infiltrate of largely plasma cells (Figure
20). Partial or complete regression of KS lesions may also
be brought about following the administration of chemo-
therapeutic agents [56,57]. Histologic examination of
such partially regressed lesions reveals residual spindled
cells around native vessels in the mid- and upper dermis,
and a significant reduction in the number of spindled
lesional cells in the intervening dermis [56]. Lesions that
have undergone complete regression, however, show an
absence of these spindled cells, and a modest increase in
microvessels (Figure 21) in relation to the superficial vas-
cular plexus [56]. Other findings include the presence of
hemosiderin-laden dermal macrophages and a conspicu-
ous superficial perivascular lymphocytic infiltrate [56].
Pyogenic granuloma-like Kaposi sarcoma manifesting as an  exophytic mass enveloped by an epidermal collarette (H&E  stain) Figure 17
Pyogenic granuloma-like Kaposi sarcoma manifest-
ing as an exophytic mass enveloped by an epidermal 
collarette (H&E stain).
Ecchymotic Kaposi sarcoma Figure 18
Ecchymotic Kaposi sarcoma. The spindled cell prolifera-
tion in this example is somewhat obscured by the extensive 
purpura.
Regressed Kaposi sarcoma lesion Figure 19
Regressed Kaposi sarcoma lesion. There is a noticeable 
increase in dermal capillary density with an associated lym-
phoplasmacytic infiltrate around native dermal vessels and 
appendages (H&E stain).Diagnostic Pathology 2008, 3:31 http://www.diagnosticpathology.org/content/3/1/31
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Conclusion
KS clearly has the ability to develop into lesions of varying
morphologic appearance. It is important to be able recog-
nize these variants in order to avoid potential misdiagno-
sis and improper management of afflicted patients. KS has
been shown to be of lymphatic origin [58]. This may
explain the intimate association of abnormal lymphatics
observed in several of these variants, such as lymphangi-
oma-like and lymphangiectatic KS. KS is also intimately
associated with lymphedema. Chronic lymphedema may
even precede KS lesions. Some authors believe that
chronic lymphedema may promote KS development due
to a combination of collateral vessel formation, lympahn-
giogenesis and immune impairment [59]. Hyperkeratotic
and bullous KS variants can be attributed to the long
standing effects of tumor-associated lymphedema on the
overlying epidermis. Deep dermal fibroma-like nodules
seen in cases associated with marked lymphedema could
explain the origin of micronodular KS. The clinical signif-
icance of most of these KS variants has not been studied.
Lymphedematous variants have been postulated to por-
tend a poor prognosis. This is certainly plausible given the
fact that significant KS-related edema carries a grave prog-
nosis [60]. Anaplastic KS is perhaps the only variant asso-
ciated with aggressive behaviour. The reason for
progressive histological dedifferentiation in some cases of
KS is unknown. Studies looking at the role of HHV-8 and
the host (e.g. immunity) in anaplastic cases may provide
some answers.
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